Acute Encephalopathy with Unilateral Cortical-Subcortical Lesions in Two Unrelated Kindreds Treated with Glucocorticoids Prenatally for Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Established Facts and Novel Insight
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prenatal glucocorticoid (GC) treatment of the female fetus with 21-hydroxylase deficiency (21-OHD) may prevent genital virilization and androgen effects on the brain, but prenatal GC therapy is controversial because of possible adverse effects on fetal programming, the cardiovascular system and the brain. CASE REPORTS: We report 2 patients with congenital adrenal hyperplasia (CAH) due to 21-OHD who were treated prenatally with dexamethasone, suffered from an acute encephalopathy and showed focal and multifocal cortical and subcortical diffusion restrictions in early MRI and signs of permanent alterations in the follow-up neuroimaging studies. Both patients recovered from the acute episode. Whereas the first patient recovered without neurological sequelae the second patient showed hemianopsia and spastic hemiplegia in the neurological follow-up examination. CONCLUSION: These are 2 children with CAH, both treated prenatally with high doses of dexamethasone to prevent virilization. The question arises whether prenatal high-dose GC treatment in patients with CAH might represent a risk factor for brain lesions in later life. Adverse effects/events should be reported systematically in patients undergoing prenatal GC treatment and long-term follow-up studies involving risk factors for cerebrovascular disease should be performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among pregnancies at risk for CAH, prenatally Dex-treated newborns have lower, but nominally normal, birth weights compared to untreated controls (470); the decrease averages ~400 g (471).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [471]
Experimental — accuracy not yet measuredIn the citing paper
“Only ;800 fetuses receiving Dex in the first trimester have been reported to date, and potential teratogenicity was not evaluated in all fetuses.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [109]
In the citing paper
“Acute encephalopathy was reported in two infants who had received prenatal Dex, but it is not clear whether this condition was related to prenatal steroid exposure (109).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825
Fetal programming of hypothalamo‐pituitary‐adrenal function: prenatal stress and glucocorticoids
Kapoor, A., Dunn, E., Kostaki, A., Andrews, M. H., & Matthews, S. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105254 · Cited by 598
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
David, M., & Forest, M. G. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80310-8 · Cited by 256
Steinlin, M., Pfister, I., Pavlovic, J., Everts, R., Boltshauser, E., Capone Mori, A., Gubser Mercati, D., Hänggeli, C.-A., Keller, E., Luetschg, J., et al. (2005) · Neuropediatrics · doi:10.1055/s-2005-837658 · Cited by 198
Self-citationForest, M. G., Bétuel, H., & David, M. (1989) · Endocrine Research · doi:10.1080/07435808909039101 · Cited by 172
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Long-Term Somatic Follow-Up of Prenatally Treated Children with Congenital Adrenal Hyperplasia1
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164
Diffusion MR Imaging of Hypoglycemic Encephalopathy
Kang, E. G., Jeon, S. J., Choi, S. S., Song, C. J., & Yu, I. K. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1856 · Cited by 154
Sartorato, P., Zulian, E., Benedini, S., Mariniello, B., Schiavi, F., Bilora, F., Pozzan, G., Greggio, N., Pagnan, A., Mantero, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1711 · Cited by 132
Ma, J.-H., Kim, Y., Yoo, W., Ihn, Y. K., Kim, J., Song, H.-H., & Kim, B. (2009) · Neuroradiology · doi:10.1007/s00234-009-0544-5 · Cited by 122
How safe is long-term prenatal glucocorticoid treatment?
Seckl, J. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540370067039 · Cited by 118
Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment
Carlson, A. D., Obeid, J. S., Kanellopoulou, N., Wilson, R. C., & New, M. I. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00059-x · Cited by 115
Heine, V. M., & Rowitch, D. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36376 · Cited by 112
DODIC, M., PEERS, A., COGHLAN, J. P., MAY, C. N., LUMBERS, E., YU, Z.-Y., & WINTOUR, E. M. (1999) · Clinical Science · doi:10.1042/cs0970103 · Cited by 99
Schwab, M., Roedel, M., Anwar, M. A., Müller, T., Schubert, H., Buchwalder, L. F., Walter, B., & Nathanielsz, P. W. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00619.x · Cited by 96
Arterial ischaemic stroke in children
Barnes, C. D., Newall, F. H., Furmedge, J., Mackay, M. T., & Monagle, P. (2004) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2004.00407.x · Cited by 89
McMahon, S. K., Pretorius, C. J., Ungerer, J. P. J., Salmon, N. J., Conwell, L. S., Pearen, M. A., & Batch, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1003 · Cited by 88
Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness
Ali, Y. S., Rembold, K. E., Weaver, B., Wills, M. B., Tatar, S., Ayers, C. R., & Rembold, C. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.003 · Cited by 73
Long-Term Outcome of Prenatal Treatment of Congenital Adrenal Hyperplasia
Lajic, S., Nordenström, A., & Hirvikoski, T. (2008) · Endocrine Development · doi:10.1159/000134827 · Cited by 67
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
A Clinical Approach to Arterial Ischemic Childhood Stroke: Increasing Knowledge over the Last Decade
Steinlin, M. I. (2012) · Neuropediatrics · doi:10.1055/s-0032-1307449 · Cited by 60
Self-citationMolnar, J., Nijland, M. J. M., Howe, D. C., & Nathanielsz, P. W. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00031.2002 · Cited by 47
Miller, W. L. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00068-x · Cited by 43
Brain White Matter Impairment in Congenital Adrenal Hyperplasia
Bergamaschi, R., Livieri, C., Uggetti, C., Candeloro, E., Egitto, M. G., Pichiecchio, A., Cosi, V., & Bastianello, S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.413 · Cited by 43
The role of the hypothalamic-pituitary-adrenal axis in preparing the fetus for birth
Liggins, S. G. C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70241-9 · Cited by 37
Dodic, M., Peers, A.-M., Coghlan, J. P., et al. (1999) · Clinical Science · doi:10.1042/cs19980356 · Cited by 37
Antenatal Glucocorticoid Treatment: Are We Doing Harm to Term Babies?
Reynolds, R. M., & Seckl, J. R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3201 · Cited by 31
Risk factors and treatment outcomes of childhood stroke
Mallick, A. A., & O'Callaghan, F. J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.106 · Cited by 29
Ritzén, E. M. (2001) · Seminars in Neonatology · doi:10.1053/siny.2001.0071 · Cited by 28
Dardis, A., & Miller, W. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790131 · Cited by 23
Chrousos, G. P., Evans, M. I., Loriaux, D. L., McCluskey, J., Fletcher, J. C., & Schulman, J. D. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb14600.x · Cited by 22
Clinical and MRI characteristics of acute encephalopathy in congenital adrenal hyperplasia
Lee, S., Sanefuji, M., Watanabe, K., Uematsu, A., Torisu, H., Baba, H., Kira, R., Takada, Y., Ishizaki, Y., Toyoshima, M., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.037 · Cited by 21
Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia
Brook, C. G. D. (2000) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.82.3.f176 · Cited by 21
Verma, S. T., Lewis, D., Warne, G. L., & Grossmann, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62266-0 · Cited by 9
Research works printed but not linked: 1
- Flück CE, Achermann JC, Miller WL: The ad- renal cortex and its disorders; in Sperling MA (ed): Pediatric Endocrinology, ed 3. Philadel- phia, Saunders, 2008, pp 444-511.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationFetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Pregnancy and Prenatal Management of Congenital Adrenal Hyperplasia
Cera, G., Locantore, P., Novizio, R., Maggio, E., Ramunno, V., Corsello, A., Policola, C., Concolino, P., Paragliola, R. M., & Pontecorvi, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206156 · Cited by 27
Khalifeh, N., Omary, A., Cotter, D. L., Kim, M. S., Geffner, M. E., & Herting, M. M. (2022) · Journal of Child Neurology · doi:10.1177/08830738221100886 · Cited by 23
Metadata
- Authors
- Grunt, S., Steinlin, M., Weisstanner, C., Schöning, M., Mullis, P. E., & Flück, C. E.
- Affiliations
- University Hospital of Bern (CH)
- University of Bern (CH)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 80
- Issue
- 1
- Pages
- 57-63
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2026426745
- Cited by
- 13
- References
- 40
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2013: 1
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Open Access CRIS of the University of Bern
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, dexamethasone, acute encephalopathy, hemianopia, spastic hemiplegia, fetal programming
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Child, Child, Preschool, Dexamethasone, Female, Fetus, Humans, Infant, Male, Pregnancy, Prenatal Care, Prenatal Exposure Delayed Effects, Virilism, Neurotoxicity Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.